Confluent Medical Technologies

Confluent Medical Technologies is a United States-based medical device contract manufacturer headquartered in Scottsdale, Arizona. The company applies materials science to MedTech innovation, specializing in the expert design, development, and large-scale manufacturing of interventional catheter-based devices and implants. Its key capabilities include Nitinol components and material, balloons and balloon catheters, complex catheters and components, high-precision polymer tubing, and implantable textiles. Confluent operates eight state-of-the-art facilities across the United States, Costa Rica, and India, and employs over 2,000 people. The company positions itself as the medical device industry's most trusted partner, emphasizing integrity, exceptional quality, and operational excellence. It serves leaders in the medical device community through a proven track record of innovation, engineering, and manufacturing. Confluent's origins trace back to 1991 with the founding of Nitinol Device and Components (NDC). After being acquired by Johnson & Johnson in 1999 and spun off in 2008, the company rebranded as Confluent Medical Technologies in 2016. Through a series of strategic acquisitions—Interface Catheters (2015), ETE Medical (2017), Corpus Medical (2018), and Tube Hollows International (2019)—Confluent expanded its capabilities into balloons, extrusions, biomedical textiles, advanced catheter development, and vertical integration of its Nitinol supply chain. In 2022, TPG Capital purchased Confluent Medical, and the company has continued to invest in capacity expansions, including a new polymer tubing center in Chattanooga (2021), a catheter center in Austin (2020), and enhanced Nitinol wire capabilities in Hyderabad, India (2023).

Confluent Medical Technologies traces its origins to 1991, when Nitinol Device and Components (NDC) was founded. The company specialized in Nitinol, a nickel-titanium alloy with unique shape-memory and superelastic properties used in minimally invasive medical devices. In 1999, NDC was acquired by Johnson & Johnson, a major healthcare conglomerate. Under J&J's ownership, NDC continued to develop its Nitinol expertise. In 2008, NDC was spun off from Johnson & Johnson to become an independent company again, retaining the NDC name. In 2010, NDC started Nitinol manufacturing in Costa Rica, expanding its geographic footprint. In 2015, NDC acquired Interface Catheters, expanding its capabilities to include balloons and extrusions. In 2016, NDC rebranded as Confluent Medical Technologies, reflecting its broader capabilities beyond Nitinol. In 2017, Confluent acquired ETE Medical and its subsidiaries, expanding into biomedical textiles. In 2018, Confluent acquired Corpus Medical to enhance its expertise in advanced catheter development. In 2019, Confluent acquired Tube Hollows International to vertically integrate its Nitinol supply chain. In 2020, Confluent opened a new catheter center in Austin, Texas, emphasizing research and development and prototyping. In 2021, Confluent established a new polymer tubing center in Chattanooga with filmcast tubing capabilities. In 2022, TPG Capital purchased Confluent Medical, taking the company private. In 2023, Confluent expanded to Hyderabad, India, for enhanced Nitinol wire capabilities. In 2024, Confluent invested in ATI Nitinol Melt Expansion. Today, Confluent operates eight state-of-the-art facilities across the United States, Costa Rica, and India, employing over 2,000 people. The company continues to apply materials science to MedTech innovation, specializing in the design, development, and large-scale manufacturing of interventional catheter-based devices and implants.

• 2024

  Confluent invested in ATI Nitinol Melt Expansion.

• 2023

  Confluent expanded to Hyderabad, India for enhanced Nitinol Wire capabilities.

• 2022

  TPG Capital purchased Confluent Medical.

• 2021

  Confluent established new Polymer Tubing center in Chattanooga with filmcast tubing capabilities.

• 2020

  Confluent opened a new Catheter center in Austin, TX emphasizing R&D and prototyping.

• 2019

  Confluent acquired Tube Hollows International to vertically integrate their Nitinol supply chain.

• 2018

  Acquired Corpus Medical to enhance expertise in advanced catheter development.

• 2017

  Confluent acquired ETE Medical and subsidiaries, expanding into biomedical textiles.

• 2016

  NDC rebranded as Confluent Medical Technologies.

• 2015

  NDC acquired Interface Catheters, expanding to include balloons and extrusions.

• 2010

  NDC started Nitinol manufacturing in Costa Rica.

• 2008

  NDC spun off from Johnson & Johnson to become NDC again.

• 1999

  NDC was acquired by Johnson & Johnson.

• 1991

  Nitinol Device and Components (NDC) was founded.

The medical device industry's most trusted partner for bringing current and future medical devices to market, emphasizing integrity, exceptional quality, and operational excellence.

• Nitinol Components

  Precision Nitinol components and material for medical devices.

• Balloon Catheters

  Balloon catheters and extrusion catheter components.

• Complex Catheters

  Complex catheter delivery systems and components.

• High-Precision Polymer Tubing

  Precision polymer tubing including filmcast PTFE.

• Implantable Textiles

  Biomedical textiles including wovens, knits, braids, and non-wovens.

1. 1Home - Confluent Medicalconfluentmedical.com
2. 2About Us - Confluent Medicalconfluentmedical.com
3. 3Corporate Responsibility - Confluent Medicalconfluentmedical.com
4. 4Culture - Confluent Medicalconfluentmedical.com
5. 5Confluent Medical Technologies - Wikidatawikidata.org